Our findings confirmed previous evidence for TNXB- and NCAM1 in the pathophysiology of depression and suggested four new potential candidate genes (LTBP3, BTN3A2, DAG1 and FHIT) that warrant further investigation. This evidence concerns the gene NCAM1 and depressive symptom measurement.